| 2022 | LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
| AUTOPHAGY |
| 2009 | Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer
| JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY |
| 2013 | Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer | HUMAN PATHOLOGY |
| 2019 | Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer | Cancer genomics & Proteomics |
| 2016 | Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
| MEDICINE |
| 2004 | Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
| PLOS PATHOGENS |
| 2014 | MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
| BMC CANCER |
| 2006 | Microarray comparative genomic hybridization을 이용한 진행된 장액성 난소암의 염색체 변화 분석 | Korean Journal of Gynecologic Oncology (부인종양) |
| 2008 | MicroRNA expression profiles in serous ovarian carcinoma
| CLINICAL CANCER RESEARCH |
| 2012 | MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
| BMC MEDICAL GENOMICS |
| 2018 | Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
| JOURNAL OF CLINICAL INVESTIGATION |
| 2021 | Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
| EXPERIMENTAL AND THERAPEUTIC MEDICINE |
| 2009 | Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
| 2009 | Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. | BIOMARKERS IN MEDICINE |
| 2022 | NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
| SCIENTIFIC REPORTS |
| 2022 | NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
| 2012 | Nanog signaling in cancer promotes stem-like phenotype and immune evasion
| JOURNAL OF CLINICAL INVESTIGATION |
| 2023 | Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
| CANCERS |
| 2003 | New approaches to functional process discovery in HPV 16-associated cervical cancer cells by gene ontology
| CANCER RESEARCH AND TREATMENT |
| 2021 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial | LANCET ONCOLOGY |
| 2002 | Osteopontin as apotential diagnostic biomarker for ovarian cancer | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2003 | Osteopontin is down-regulated in hydatidiform mole | GYNECOLOGIC ONCOLOGY |
| 2016 | Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
| INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY |
| 2022 | Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2013 | Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer. | CANCER INVESTIGATION |
| 2018 | Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer | BRITISH JOURNAL OF CANCER |
| 2015 | PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
| NATURE COMMUNICATIONS |
| 2009 | Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer | ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA |
| 2008 | Platinum 제제가 포함된 항암화학요법을 받은 부인암 환자에서의 당뇨병 발생 위험 | Korean Journal of Obstetrics and Gynecology (대한산부인과학회지) |
| 2016 | Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
| BMC CANCER |
| 2013 | Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2012 | Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
| 2009 | Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment | CANCER IMMUNOLOGY IMMUNOTHERAPY |
| 2017 | Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study | CANCER |
| 2009 | Preoperative levels of plasma micronutrients are related to endometrial cancer risk | ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA |
| 2018 | Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
| Obstetrics & Gynecology Science |
| 2005 | Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS |
| 2021 | Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
| CANCER SCIENCE |
| 2010 | Prevalence and clinical relevance of cyclooxygenase-1 and -2 expression in stage IIB cervical adenocarcinoma | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
| 2010 | Prevalence and seroprevalence of high-risk human papillomavirus infection | OBSTETRICS AND GYNECOLOGY |
| 2012 | Prevalence and seroprevalence of low-risk human papillomavirus in Korean women
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2016 | Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
| ONCOTARGET |
| 2013 | Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry
| JOURNAL OF TRANSLATIONAL MEDICINE |
| 2006 | Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS |
| 2012 | Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma. | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2018 | Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer | GYNECOLOGIC ONCOLOGY |
| 2019 | Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
| BMC CANCER |
| 2015 | Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis
| ONCOTARGET |
| 2015 | Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer | PATHOBIOLOGY |
| 2005 | Prognostic significance of DNA quantification by flow cytometry in ovarian tumors | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS |
| 2020 | Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer
| CANCER GENOMICS & PROTEOMICS |
| 2008 | Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
| 2023 | Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | PROSPECTIVE MULTI-INSTITUTIONAL PHASE III TRIAL OF STANDARD OF CARE THERAPY WITH OR WITHOUT STEROTACTIC ABLATIVE RADIATION THERAPY FOR RECURRENT OVARIAN CANCER (SABR-ROC, KGOG 3064/KROG 2204) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2016 | Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer
| ONCOTARGET |
| 2016 | Relationship Between Gonadotropin-Releasing Hormone/Gonadotropin-Releasing Hormone Receptor Signaling and Progesterone Receptors in Human Trophoblasts | JOURNAL OF REPRODUCTIVE MEDICINE |
| 2009 | Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study | CLINICAL CHEMISTRY AND LABORATORY MEDICINE |
| 2022 | RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer | JOURNAL OF GENE MEDICINE |
